SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-02-002817
Filing Date
2002-03-22
Accepted
2002-03-22 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 REGENERON PHARMACEUTICALS, INC. y58194e10-k.htm 10-K 779336
3 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORP. y58194ex10-2.txt EX-10.2 2643
4 2000 LONG-TERM INCENTIVE PLAN. y58194ex10-6.txt EX-10.6 68461
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP y58194ex23-1.txt EX-23.1 716
6 CONSENT OF ERNST & YOUNG LLP y58194ex23-2.txt EX-23.2 1289
7 POWER OF ATTORNEY y58194ex24.txt EX-24 1404
  Complete submission text file 0000950123-02-002817.txt   855901
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19034 | Film No.: 02582666
SIC: 2834 Pharmaceutical Preparations